A Laboratory Case of Emergomyces Africanus [PDF]
The Journal of Medical Laboratory Science & Technology of South Africa, 2022 Emergomyces africanus (Es. africanus) is a novel thermally-dimorphic fungal pathogen, which belongs to the Ajellomycetaceae family. Several species have been described within the Emergomyces genus, namely Es. africanus, Es. canadensis, Es.
Nokuthula Linda, Lee-ann Mabulwana
exaly +6 more sources
Exploring Polyamine Metabolism of the Yeast-Like Fungus, Emergomyces Africanus [PDF]
FEMS Yeast ResearchEmergomyces africanus is a thermally dimorphic pathogen causing severe morbidity and mortality in immunocompromized patients. Its transition to a pathogenic yeast-like phase in the human host is a notable virulence mechanism.
Nelesh P Govender +2 more
exaly +5 more sources
First Report of Urease Activity in the Novel Systemic Fungal Pathogen Emergomyces Africanus: A Comparison With the Neurotrope Cryptococcus neoformans. [PDF]
FEMS Yeast Research, 2017 Cryptococcus neoformans is an opportunistic pathogen responsible for the AIDS-defining illness, cryptococcal meningitis. During the disease process, entry of cryptococcal cells into the brain is facilitated by virulence factors that include urease enzyme activity.
Nelesh P Govender +2 more
exaly +7 more sources
Correction: Molecular detection of airborne Emergomyces africanus, a thermally dimorphic fungal pathogen, in Cape Town, South Africa. [PDF]
PLoS Neglected Tropical Diseases, 2018 [This corrects the article DOI: 10.1371/journal.pntd.0006174.].
PLOS Neglected Tropical Diseases Staff
doaj +6 more sources
Erratum for Honorato et al., “Extracellular vesicles of Emergomyces africanus modulate host immune responses and reflect metabolic adaptations to nutrient availability” [PDF]
Infection and ImmunityLeandro Honorato +14 more
doaj +5 more sources
The pathogenesis of experimental Emergomycosis in mice. [PDF]
PLoS Neglected Tropical Diseases, 2023 Emergomyces africanus is a recently identified thermally-dimorphic fungal pathogen that causes disseminated infection in people living with advanced HIV disease. Known as emergomycosis, this disseminated disease is associated with very high case fatality
Maxine A Höft +8 more
doaj +3 more sources
Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects [PDF]
Frontiers in Medicine, 2021 Recently, the global emergence of emergomycosis, a systemic fungal infection caused by a novel dimorphic fungus Emergomyces species has been observed among immunocompromised individuals.
Arghadip Samaddar, Anuradha Sharma
doaj +3 more sources
Emergomycosis in Africa: Time to Pay Attention to This Emerging Deadly Fungal Infection [PDF]
International Journal of General Medicine, 2023 Chibuike Ibe,1 Nicholaus P Mnyambwa,2,3 Sayoki G Mfinanga2 1Department of Microbiology, Faculty of Biological Sciences, Abia State University, Uturu, Nigeria; 2National Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania ...
Ibe C, Mnyambwa NP, Mfinanga SG
doaj +3 more sources
In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients. [PDF]
J Clin Microbiol, 2017 ABSTRACT Disseminated emmonsiosis is an important AIDS-related mycosis in South Africa that is caused by Emergomyces africanus , a newly described and renamed dimorphic fungal pathogen.
Maphanga TG +6 more
europepmc +6 more sources
Cbp1, a fungal virulence factor under positive selection, forms an effector complex that drives macrophage lysis. [PDF]
PLoS Pathogens, 2022 Intracellular pathogens secrete effectors to manipulate their host cells. Histoplasma capsulatum (Hc) is a fungal intracellular pathogen of humans that grows in a yeast form in the host.
Dinara Azimova +8 more
doaj +3 more sources